Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence

PARPi in the treatment of recurrent disease

Date

22 Sep 2020

Session

GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence

Presenters

Jonathan Ledermann

Authors

J.A. Ledermann

Author affiliations

  • Cancer Trials Centre, UCL Cancer Institute - UCL - London's Global University, WC1 E6BT - London/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Antonio González Martín

Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.